---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-25-053325"
form_type: "8-K"
ticker: "TCRT"
cik: "0001107421"
company_name: "Alaunos Therapeutics, Inc."
filed_at: "2025-04-11T23:59:59+00:00"
generated_at: "2026-05-23T15:55:33.778593+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Alaunos receives Nasdaq deficiency notice for equity below $2.5M minimum; 45 days to submit plan

## Summary
- Stockholders' equity of $2.063M as of Dec 31, 2024, falls short of Nasdaq's $2.5M minimum under Rule 5550(b)(1).
- Company has 45 days from Apr 7, 2025 to submit a compliance plan; if accepted, may have up to 180 days to cure.
- Nasdaq also removed the one-year Panel Monitor that had been in place since February 2024.
- The deficiency notice does not immediately affect listing, but non-compliance could lead to delisting.
- Company intends to evaluate options and submit a plan to regain compliance within the allowed timeframe.

## SEC filing metadata
- accession: 0000950170-25-053325
- form_type: 8-K
- ticker: TCRT
- cik: 0001107421
- company_name: Alaunos Therapeutics, Inc.
- filed_at: 2025-04-11T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 3.01, 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1107421/000095017025053325/0000950170-25-053325-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1107421/000095017025053325/tcrt-20250407.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-25-053325
- JSON: https://secwatch.observer/filing/0000950170-25-053325.json
- Plain text: https://secwatch.observer/filing/0000950170-25-053325.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.